Skip to content
The Interventional Glaucoma Podcast

Episode 2: Spotlight on Excimer Lasers

Professor Gus Gazzard is joined by Ahmad Elsahn to delve into the use of excimer laser technology and its impact in shifting mindsets towards more interventional strategies for glaucoma patients. They provide insights into the distinct characteristics of the excimer laser, and discuss the safety and efficacy of the treatment.

Key Takeaways

  • Characteristics of Excimer Lasers: The excimer laser differs from other optical lasers due to its formation process involving a noble gas and a halogen, resulting in ultraviolet laser emission with high precision and no thermal effect.
  • High Precision: Excimer laser precision and non-thermal approach protects the integrity of adjacent tissues and collector channels with minimal scar formation and inflammatory responses.
  • Cold Laser Technology: Contrary to common laser associations with heat, excimer laser is a non-thermal laser that creates controlled openings in the trabecular meshwork to facilitate aqueous outflow, thereby reducing IOP.
  • Efficacy and Long-Term Safety: Excimer trabeculotomy has demonstrated effectiveness in reducing intraocular pressure and is backed by long-term follow-up data [1-4] and basic underpinning clinical research, showing promising results in terms of safety and pressure-lowering effects.

Guests

Prof. Gus Gazzard

Professor Gus Gazzard is Director of Surgery at Moorfields Eye Hospital and Professor in Ophthalmology, Glaucoma Studies at UCL London. He has joined the Glaucoma Research Society as one of the top 100 glaucoma researchers in the field and is leading author of multiple publications on MIGS surgery.

Ahmad Elsahn

Ahmad Elsahn is currently the Head of Service of Ophthalmology at Sherwood Forest Hospitals NHS Foundation Trust in the UK. He has a strong background in clinical ophthalmology and cutting-edge basic science and clinical research. He has worked as a specialist ophthalmologist in three continents over the last 20 years, with a keen interest in clinical research.

Episode 10: Glaucoma Management Five Years From Now

Dr. Karl Mercieca, Dr. Gok Ratnarajan, and Dr. Ana Miguel discuss the future of glaucoma management.

Episode 9: Physician experiences with ELIOS and the rationale for routinely combining MIGS with cataract surgery

Dr Jose Belda, Dr María Isabel Canut, and Dr Marta Ibarz discuss the rationale and benefits of routinely combining MIGS with cataract surgery.

Episode 8: TM-MIGS: Impact on patient quality of life

Professor Christophe Baudouin, Mr Gok Ratnarajan, and Dr Ana Miguel discuss the impact of glaucoma treatments on patients' quality of life.